Risk Factors of Porphyria Cutanea Tarda (PCT)

University Hospital, Strasbourg, France280 enrolled

Overview

Comparison of patients with documented PCT and HCV infection, documented PCT without HCV, HCV infection without PCT and controls without HCV or PCT. Single blood + urine sample uptake to investigate : mutations in HFE gene, uroporphyrinogen decarboxylase activity, HCV genotye, history of disease.

Study Type

OBSERVATIONAL

Enrollment

280

Conditions

Porphyria Cutanea Tarda

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Porphyria cutanea tarda /HCV negative Porphyria cutanea tarda/ HCV positive HCV positive HCV negative controls

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.